DESCRIPTION: Minoxigain F 5% is a lipid-based topical solution that combines two scientifically proven agents for the treatment of androgenetic alopecia (male pattern baldness): Minoxidil, a potent vasodilator that stimulates hair follicles to promote regrowth, and Finasteride, a 5α-reductase inhibitor that reduces scalp dihydrotestosterone (DHT), the primary hormone responsible for hair loss.
DOSAGE FORM: Liquid
ROUTE OF ADMINISTRATION: Topical
COMPOSITION: Each ml contains:
Minoxidil IP 5% w/v
Finasteride IP 0.1% w/v
Base q.s.
MECHANISM OF ACTION: Minoxigain F 5% Topical Solution works through a dual mechanism: Minoxidil: Increases blood flow to the hair follicles, prolongs the anagen (growth) phase, and enlarges miniaturized follicles, leading to thicker hair strands. Finasteride: Inhibits the conversion of testosterone to dihydrotestosterone (DHT), thereby reducing miniaturization of hair follicles and preventing further hair loss. Together, they work synergistically to: Stimulate dormant follicles, prevent hair thinning, reduce hair fall and Encourage visible hair regrowth.
INDICATION: Minoxigain F 5% Topical Solution is indicated for the treatment of alopecia androgenetica (male pattern baldness) in men in the age group of 18 to 60 years.
DOSE & METHOD OF ADMINISTRATION: For external use only. Use only as directed.
A total dose of 1ml Minoxigain F 5% Topical Solution should be applied twice per day to the affected scalp. This dose should be used regardless of the size of the affected area. The total daily dose should not exceed 2ml. Minoxigain F 5% Topical Solution should be applied when the hair and scalp are thoroughly dry. Do not use a hairdryer to speed the drying of the topical solution because blowing air on the scalp may decrease the effectiveness of the drug.
Minoxigain F 5% Topical Solution shall not be mixed with any hair oil nor shall it be applied to other body parts. Hands should be thoroughly washed after application.
Clinical experience with Minoxidil & Finasteride solution indicates that application for 4 or more months may be required before evidence of hair growth stimulation can be expected.
SIDE EFFECTS: Scalp itching or dryness, flaking or irritation, mild burning sensation.
CONTRAINDICATIONS: Minoxigain F 5% Topical Solution is contraindicated in hypersensitivity to Minoxidil or any of the constituents of the solution and scalp dermatologic conditions (eczema, sunburn, infections). Not recommended in women, especially during pregnancy or breastfeeding.
DRUG INTERACTION: There are currently no known drug interactions associated with the use of Minoxidil or finasteride topical administration. Although it has not been clinically demonstrated, there exists the possibility of Minoxidil potentiating orthostatic hypotension in patients concurrently taking Guanethidine.
STORAGE: Store at a temperature not exceeding 25°C. Protect from light. Do not freeze.
PRESENTATION: 60 ml with Derma Roller, Drop & Spray.